Terms: = Head and neck cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
2820 results:
1.
Prabhash K; Saldanha E; Patil V; Bal M; Reddy P S; Sanjeev A; Kumar R; Poojary D; Noronha V; Menon N; Mittal N; Trivedi V; Nambiar K; Mishra R; Tanwar N; Malhotra R; Pange P; Gupta V; Veldore VH; Chougule A; Chaturvedi P; Dutt A; Chandrani P
JCO Precis Oncol; 2024 May; 8():e2300622. PubMed ID: 38754058
[TBL] [Abstract] [Full Text] [Related]
2. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
3. Timing and Ideal Patient for an Appropriate Search for Somatic
Matrone A; Prete A; Gambale C; Elisei R
JCO Precis Oncol; 2024 May; 8():e2400017. PubMed ID: 38709990
[TBL] [Abstract] [Full Text] [Related]
4. Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid cancer: Long-Term Experience in a Patient With Multiple Endocrine Neoplasia Type 2B.
Réti Z; Tabák ÁG; Garami M; Kalina I; Kiss G; Sápi Z; Tóth M; Tőke J
JCO Precis Oncol; 2024 May; 8():e2300675. PubMed ID: 38709988
[TBL] [Abstract] [Full Text] [Related]
5. Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options.
Jara MA
Crit Rev Oncog; 2024; 29(3):83-90. PubMed ID: 38683155
[TBL] [Abstract] [Full Text] [Related]
6. Predictors of radioiodine (RAI)-avidity restoration for Ntrk fusion-positive RAI-resistant metastatic thyroid cancers.
Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
[TBL] [Abstract] [Full Text] [Related]
7. Estimating the Prognostic Value of the Ntrk Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
Santi I; Vellekoop H; M Versteegh M; A Huygens S; Dinjens WNM; Mölken MR
Mol Diagn Ther; 2024 May; 28(3):319-328. PubMed ID: 38616205
[TBL] [Abstract] [Full Text] [Related]
8. Correlation of
Ueda CE; Flausino Dias L; de Godoi Carneiro C; Sapienza MT; Alberto Buchpiguel C; Schiavom Duarte P
Arch Endocrinol Metab; 2024 Apr; 68():e230152. PubMed ID: 38602746
[TBL] [Abstract] [Full Text] [Related]
9. Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry.
Katabi N
Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
[TBL] [Abstract] [Full Text] [Related]
10. Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer.
Liu Z; Zhang X; Zhao X; Guo Q; Li Z; Wei M; Niu L; An C
BMC Med Imaging; 2024 Mar; 24(1):64. PubMed ID: 38500053
[TBL] [Abstract] [Full Text] [Related]
11. Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care - A systematic review.
Cohen O; Tzelnick S; Randolph G; Rinaldo A; Álvarez F; Rodrigo JP; Saba NF; Nuyts S; Corry J; Mäkitie AA; Vander Poorten V; Nathan CA; Piazza C; Ferlito A
Clin Endocrinol (Oxf); 2024 May; 100(5):468-476. PubMed ID: 38472743
[TBL] [Abstract] [Full Text] [Related]
12. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
[No Abstract] [Full Text] [Related]
13. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract] [Full Text] [Related]
14. Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000-2020: a population-based retrospective cohort study.
Tao Z; Deng X; Guo B; Ding Z; Fan Y
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38376827
[TBL] [Abstract] [Full Text] [Related]
15. The role of prophylactic parathyroidectomy during thyroidectomy for mtc in patients with MEN2A syndrome.
Kavazis C; Romanidis K; Pitiakoudis M; Kesisoglou I; Laskou S; Sapalidis K
Folia Med (Plovdiv); 2023 Oct; 65(5):720-727. PubMed ID: 38351753
[TBL] [Abstract] [Full Text] [Related]
16. Glucagon-Like Peptide-1 Receptor Agonists and Thyroid cancer: A Narrative Review.
Espinosa De Ycaza AE; Brito JP; McCoy RG; Shao H; Singh Ospina N
Thyroid; 2024 Apr; 34(4):403-418. PubMed ID: 38343381
[No Abstract] [Full Text] [Related]
17. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
[TBL] [Abstract] [Full Text] [Related]
18. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
19. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
20. Extent of Surgery for Medullary Thyroid cancer and Prevalence of Occult Contralateral Foci.
Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
[TBL] [Abstract] [Full Text] [Related]
[Next]
